Novel Fentanyl-Based Dual Μ/Δ-Opioid Agonists for the Treatment of Acute and Chronic Pain

Life Sciences - United States
doi 10.1016/j.lfs.2013.09.016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Development of Novel Enkephalin Analogues That Have Enhanced Opioid Activities at Both Μ and Δ Opioid Receptors

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2007English

Determinants of Fentanyl and Other Potent Μ Opioid Agonist Misuse in Opioid-Dependent Individuals

Pharmacoepidemiology and Drug Safety
EpidemiologyPharmacology
2010English

Synergistic Attenuation of Chronic Pain Using Mu Opioid and Cannabinoid Receptor 2 Agonists

Neuropharmacology
Molecular NeuroscienceCellularPharmacology
2017English

Safety and Efficacy of the Unique Opioid Buprenorphine for the Treatment of Chronic Pain

Journal of Pain Research
AnesthesiologyPain Medicine
2019English

Opioid Therapy for Chronic Pain

New England Journal of Medicine
Medicine
2003English

Absence of G-Protein Activation by Μ-Opioid Receptor Agonists in the Spinal Cord of Μ-Opioid Receptor Knockout Mice

British Journal of Pharmacology
Pharmacology
1999English

Opioid Peptidomimetics: Leads for the Design of Bioavailable Mixed Efficacy Μ Opioid Receptor (MOR) Agonist/Δ Opioid Receptor (DOR) Antagonist Ligands

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2013English

Differential Effect of Membrane Cholesterol Removal on Μ- And Δ-Opioid Receptors

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2009English

Polymer Based Therapies for the Treatment of Chronic Pain

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy